Risk-stratified Cancer Screening
Special Issue Information
Dear Colleagues
There are inter-individual variations in the risk of developing cancer and in the potential to benefit from cancer screening. These variations could inform early detection strategies (such as whom and how often to screen) in a way to improve the efficiency of cancer screening programmes and reduce the harm of overdiagnosis and overtreatment. This could be achieved by shifting from one-size-fits all to more risk-stratified screening approach. The implementation of risk-stratifed cancer screening approaches raises a number of technical, organisational, ethical, legal, and social challenges that need to be addressed to realise the full potential of risk-stratified screening.
We are inviting submission of original articles to a Special Issue of the Journal of Personalized Medicine that covers the whole spectrum of risk-stratified cancer screening—from risk assessment to generating the evidence on effectiveness and cost-effectiveness, on the ways to communicate risk, to gain the public trust, to prepare and train the workforce, to assess healthcare organisational readiness, and to develop pilot models of implementation and the evaluation of outcomes.
Dr. Nora Pashayan
Dr. Hermann Nabi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Risk prediction test
- Polygenic risk score
- Genetic mutations
- Epigenetic markers
- Prevention
- Risk stratified screening, precision screening
- Cancer
- Cost-effectiveness
- Benefit-harm trade offs
- Acceptability
- Communication
- Behavioural change
- Workforce training
- ELSI
- Healthcare organization
- Electronic health records
- Big data
- Implementation
- Outcome research
- Precision public health
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Published Papers
J. Pers. Med. - ISSN 2075-4426